Please provide your email address to receive an email when new articles are posted on . The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients ...

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

The FDA approved a once-monthly, single-injection regimen for Omvoh, enhancing convenience for UC patients. Omvoh, an IL-23p19 antagonist, offers bioequivalent efficacy to the previous two-injection ...

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) ...

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...

Supernatural, housed in the old SoulCycle Yorkville location, is a 5,000-square-foot facility promising that, if we manage ...

Losing one’s hair is common. It is not only psychologically debilitating, but it can have a major effect on self-esteem. It’s not surprising then that a huge market in hair loss supplements has sprung ...